Thursdays Stocks To Watch - WAMUQ, QING, GRDO, VPRS

WAMUQ As far as I understand this play, people buying WAMUQ are betting that JPM was wrong in taking Washington Mutual and its assets from them. The assumption is that shareholders of WAMUQ would stand to make out if JPM is proven wrong in its handling of the WAMU takeover. Only a few weeks ago this was at $.04 and today hit a high of $.23, a nice huge return for anyone that was in from the start of the recent run. I think this stock will remain in play for a while.

QING boasts a p/e of .61. Your typical, profitable company usually has a p/e of at least 10, which means QING should be trading at $4.00+ and not $.24. If you factor in the recent quarterly eps of $.15 then this stock should really be trading at $6.00 or $9.00. I think its only a matter of time before the market comes upon this glaring undervaluation.

GRDO with its share structure currently maxed out, this stock should rebound smartly from recent lows. I think the stock should continue to impress in the near term.

VPRS the stock is quietly climbing higher as we await further details about the possible reverse merger taking place. A recent 8k filing shows the shell was bought and the new CEO being the CEO of a privately held Chinese medical company. The drug they are marketing would, according to a recent document, provide substantial income and revenue: Vivatuxin® is expected to generate $45.1 million revenue and $13.8 million net profit in 2011, $92.8 million revenue and $36.1 million net profit in 2012, and $143.3 million revenue and $52.1 million net profit in 2013.